MedPath

nderstanding breathlessness in interstitial lung disease

Phase 4
Recruiting
Conditions
Interstitial Lung disease
Respiratory - Other respiratory disorders / diseases
Registration Number
ACTRN12621000049875
Lead Sponsor
niversity of Auckland
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
15
Inclusion Criteria

•Patients with fibrotic ILD (total lung capacity <80% predicted; FEV1/FVC > 0.7 and standard HRCT criteria (British Thoracic Society guidelines 2008)
•Aged 18 years or over

Exclusion Criteria

•More than 10 pack year smoking history
•Evidence of significant emphysema on CT scan
•Pulmonary Sarcoidosis
•Currently taking regular inhaled therapy for airways disease
•Serious co-morbidities that may contribute to dyspnoea and/or reduce exercise capacity including:
oSevere respiratory disease other than ILD (e.g., chronic obstructive pulmonary disease)
oPulmonary hypertension
oSevere obesity (Body mass index > 35 kg/m2)
oSevere orthopaedic impairment or rheumatologic disease
oSignificant neurological disease
oInfection or pyrexial illness

•Presence of any contraindications to cardiopulmonary exercise testing
oUnstable angina or recent acute myocardial infarction
oUncontrolled arrhythmias causing symptoms or haemodynamic compromise
oSymptomatic severe aortic stenosis
oOxygen saturation <85% at rest on room air
oUncontrolled heart failure
oUncontrolled asthma
oUncontrolled thyroid disorders
oMental impairment leading to inability to cooperate

•Current pregnancy
•Allergy or intolerance to dopamine.
•Current users of recreational drugs
•Current abusers of alcohol
•Inability to fully or appropriately provide consent (e.g., language issue, reading capability)
•Underlying medical conditions, which in the opinion of the Investigator place the participant at unacceptably high risk for participating in the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath